Therapeutic targeting of soluble CD146/MCAM with the M2J‐1 monoclonal antibody prevents metastasis development and procoagulant activity in CD146‐positive invasive tumors - Aix-Marseille Université Access content directly
Journal Articles International Journal of Cancer Year : 2020

Therapeutic targeting of soluble CD146/MCAM with the M2J‐1 monoclonal antibody prevents metastasis development and procoagulant activity in CD146‐positive invasive tumors

Aurelie Leroyer
  • Function : Author
  • PersonId : 1121395
Centre recherche en CardioVasculaire et Nutrition = Center for CardioVascular and Nutrition research
Jimmy Stalin
Wael Traboulsi
  • Function : Author
  • PersonId : 775166
  • IdRef : 219516014
Lucie Vivancos‐stalin
  • Function : Author
Marie Nollet
  • Function : Author
Ahmad Joshkon
Richard Bachelier
Benjamin Guillet
  • Function : Author
Romaric Lacroix
Alexandrine Foucault‐bertaud
  • Function : Author
Françoise Dignat‐george
  • Function : Author
Nathalie Bardin
Marcel Blot‐chabaud

Domains

Life Sciences [q-bio]

Aurelie Leroyer  : Connect in order to contact the contributor

https://hal-amu.archives-ouvertes.fr/hal-03504360

Submitted on : Wednesday, December 29, 2021-9:56:01 AM

Last modification on : Sunday, June 26, 2022-10:26:56 AM

Not file

Dates and versions

hal-03504360 , version 1 (29-12-2021)

Identifiers

Cite

Aurelie Leroyer, Jimmy Stalin, Wael Traboulsi, Lucie Vivancos‐stalin, Marie Nollet, et al.. Therapeutic targeting of soluble CD146/MCAM with the M2J‐1 monoclonal antibody prevents metastasis development and procoagulant activity in CD146‐positive invasive tumors. International Journal of Cancer, 2020, 147 (6), pp.1666-1679. ⟨10.1002/ijc.32909⟩. ⟨hal-03504360⟩

Export

BibTeX TEI Dublin Core DC Terms EndNote Datacite

Collections

UNIV-AMU INRAE INCIAM
8 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More